Journal of Neuro-Oncology

*Editorial Board Spotlight* Dr. Alfredo Quinones-Hinojosa focuses his clinical practice on primary and metastatic brain tumors using motor and speech mapping @mayoclinic. He also leads research on cell migration and brain tumors. Thanks! #JNO

*Editorial Board Spotlight* Dr. Alfredo Quinones-Hinojosa focuses his clinical practice on primary and metastatic brain tumors using motor and speech mapping @mayoclinic. He also leads research on cell migration and brain tumors. Thanks! #JNO

*Editorial Board Spotlight* Dr. Patrick Roth is a senior physician in the Department of Neurology at the University of Zurich. His research focuses on the use of immunotherapy in primary and metastatic brain tumors. Thanks! #JNO

Kite et al @ahnneuroscience reviewed over two decades of outcomes for recurrent high-grade gliomas treated with stereotactic radiosurgery #JNO Read more: ow.ly/7CN250Wt1zc

*Editorial Board Spotlight* Dr. Tejpal Gupta is a professor and Officer-in-Charge of radiation oncology at the Tata Memorial Hospital in Mumbai, Maharashtra, India. His research interests center on the use of tomotherapay in head and neck cancers. Thanks! #JNO

*Editorial Board Spotlight* Dr. Antonio Silvani is the Chief of Neuro-Oncology at the Fondazione IRCCS Istituto Neurologico Carlo Besta in Milan, Italy. He additionally studies immunotherapy in the treatment of glioblastoma. Thanks! #JNO

Fiedler et al. analyzed the CPT-SIOP registry for pediatric choroid plexus papilloma, revealing that incomplete resection and the “pediatric B” molecular subgroup are key risk factors for progression, particularly in aCPP cases. #JNO Read more:link.springer.com/article/10.100…

*Editorial Board Spotlight* Dr. Shi-Yuan Cheng is a professor of neuro-oncology @nufeinbergmed. He studies cancer stem cell biology, cell signaling, and therapy responses in brain tumors. Thanks! #JNO

*Editorial Board Spotlight* Dr. Robert Prins is the PI of Brain Tumor Immunology Lab @uclaneurosurgery and studies immunotherapy for targeting CNS tumors. He also leads the laboratory component of UCLA's immunotherapy clinical trials for glioblastoma. Thanks! #JNO

Koçyiğit et al @saidkocyigit @acibademuni showed that posterior parasagittal meningiomas exhibit aggressive features—such as higher grade and brain invasion—independent of size, highlighting critical role of tumor location in risk stratification.#JNO link.springer.com/article/10.100…

*Editorial Board Spotlight* Dr. Ian Dunn is the Harry Wilkins, MD Chairman and Professor of Neurosurgery @ou_neurosurgery. He is a leader in skull base and pituitary brain tumor research with 200+ peer-reviewed publications. #JNO

Barton et al assessed psychosocial functioning in children with NF1 and cognitive impairments, showing poorer HRQoL than healthy peers and even children with cancer. Social stress and depression were key predictors of poor outcomes. #JNO Read more:link.springer.com/article/10.100…

Our lab specialist Antony Dela Cruse took a break from his very schedule in the lab to walk you through another busy week here at #SSF #cancer #braintumor @cedarssinai @randydamico #TumorTalk @jasonsheehanmd @nstumorsection @jneurooncol #neurosurgery #neuroonc #braintumor

The cancer center’s D. Wade Clapp, MD, and colleagues have published their latest findings in the Journal of Neuro-Oncology. Learn more: ow.ly/elPY50Win4s. #ResearchCuresCancer #NCIcomprehensive @JNeurooncol

Fiedler et al. studied pediatric choroid plexus papillomas and found extent of initial resection and tumor molecular markers as predictors for adjuvant therapy and repeat resections. #JNO #pediatriccancer link.springer.com/article/10.100…

Gensler et al. used the TriNetX global health research network to identify 7,887 patients with leptomeningeal disease. Vertebral LMD was associated with significantly poorer outcomes, particularly for patients with primary breast cancers. #JNO link.springer.com/article/10.100…

Laribi et al. examined long-term impact of antiseizure medication in meningioma patients and found no significant association between ASM use and depression, anxiety, or neurocognitive dysfunction, providing reassurance for management. #JNO Read more:link.springer.com/article/10.100…

Torres et al. analyzed 176 IDH-WT GBM tumors to identify gene mutations associated with cystic GBMs. #JNO link.springer.com/article/10.100…

Mahapatra et al. @Tulane evaluated minimally invasive keyhole craniotomy combined with Cs-131 brachytherapy for brain oligometastases, demonstrating excellent local control (91.7% at 1 year) with minimal toxicity and preserved function. #JNO Read more:link.springer.com/article/10.100…

*Editorial Board Spotlight* Dr. Giuseppe Minniti is a Clinical Associate Professor with UPMC San Pietro. He has authored over 200 peer-reviewed publications on the optimization of radiotherapy and SRS for primary and metastatic brain tumors. #JNO